The company also claimed it's acquired regulatory clearance to start Section 2 medical trials for just a new drug while in the U.S. later this year. The cookie is set with the GDPR Cookie Consent plugin and is also accustomed to store whether user has consented to using cookies. https://financefeeds.com/5-reasons-to-meet-solitics-at-ifx-expo-international-2024/